These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12042782)

  • 21. CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression.
    Malhotra U; Huntsberry C; Holte S; Lee J; Corey L; McElrath MJ
    Clin Immunol; 2006 Apr; 119(1):95-102. PubMed ID: 16403675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
    J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.
    Younes SA; Yassine-Diab B; Dumont AR; Boulassel MR; Grossman Z; Routy JP; Sekaly RP
    J Exp Med; 2003 Dec; 198(12):1909-22. PubMed ID: 14676302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers.
    Mekonnen Y; Geskus RB; Hendriks JC; Messele T; Borghans J; Miedema F; Wolday D; Coutinho RA; Dukers NH
    J Infect Dis; 2005 Sep; 192(5):739-48. PubMed ID: 16088823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
    Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
    Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamics of T lymphocyte subsets in HAART treated AIDS patients with successful suppression of HIV replication and different CD4 + T cell restoration].
    Qiu ZF; Li TS; Ruan GR; Han Y; Xie J; Zuo LY; Li YL; Wang AX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):386-90. PubMed ID: 16900640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of upstream U3 sequences in HIV-1 replication and CD4+ T cell depletion in human lymphoid tissue ex vivo.
    Münch J; Rajan D; Rücker E; Wildum S; Adam N; Kirchhoff F
    Virology; 2005 Oct; 341(2):313-20. PubMed ID: 16102792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
    Betts MR; Gray CM; Cox JH; Ferrari G
    Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Caution in the interpretation of CD4 lymphocyte count after splenectomy in patients with HIV infection].
    Boudes P; Casassus P; Guillevin L
    Ann Med Interne (Paris); 1988; 139(7):523. PubMed ID: 2907719
    [No Abstract]   [Full Text] [Related]  

  • 31. Changing virus-host interactions in the course of HIV-1 infection.
    Miedema F; Meyaard L; Koot M; Klein MR; Roos MT; Groenink M; Fouchier RA; Van't Wout AB; Tersmette M; Schellekens PT
    Immunol Rev; 1994 Aug; 140():35-72. PubMed ID: 7821927
    [No Abstract]   [Full Text] [Related]  

  • 32. The natural history of HIV-1 infection in Africa.
    Morgan D; Whitworth J
    Nat Med; 2001 Feb; 7(2):143-5. PubMed ID: 11175832
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on Mosier and Sieburg.
    Schuitemaker H; Miedema F
    Immunol Today; 1995 Jan; 16(1):50-2. PubMed ID: 7880389
    [No Abstract]   [Full Text] [Related]  

  • 34. An alternative strategy for therapy of AIDS; a cure?
    Colaco CA
    Med Hypotheses; 1990 Jun; 32(2):157-8. PubMed ID: 1974026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1: the infective process in vivo.
    McCune JM
    Cell; 1991 Jan; 64(2):351-63. PubMed ID: 1988152
    [No Abstract]   [Full Text] [Related]  

  • 36. Nutritional status and survival in HIV-1 disease.
    Baum MK; Shor-Posner G
    AIDS; 1997 Apr; 11(5):689-90. PubMed ID: 9108956
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular biology of HIV: challenges for the second decade.
    Poeschla E; Wong-Staal F
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):111-2. PubMed ID: 8198866
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroendocrine function in acquired immunodeficiency syndrome.
    Rapaport R; McSherry G; Connor E; Oleske J
    J Pediatr; 1991 May; 118(5):828. PubMed ID: 2019947
    [No Abstract]   [Full Text] [Related]  

  • 39. CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option.
    Műzes G; Sipos F
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.
    Gobran ST; Ancuta P; Shoukry NH
    Front Immunol; 2021; 12():726419. PubMed ID: 34456931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.